Africa carries the greatest burden of disease caused by Plasmodium falciparum, and we can expect this burden to rise in the near future, mainly because of drug resistance. Although effective drugs are available (such as artemether-lumefantrine, mefloquine, atovaquone-proguanil and halofantrine) they are uniformly too expensive for routine use. Affordable options include chloroquine plus sulfadoxine-pyrimethamine (SP), amodiaquine (alone or in combination with SP) and chlorproguanil-dapsone. A...Expand abstract
- Publication status:
- Publisher copy:
- Copyright date:
Clinical status and implications of antimalarial drug resistance.
If you are the owner of this record, you can report an update to it here: Report update to this record